[{"id":"3c7ad206-aabe-45c5-80cd-3b3f8bdfdc31","acronym":"BC-BOMET","url":"https://clinicaltrials.gov/study/NCT04167605","created_at":"2022-10-19T07:56:10.751Z","updated_at":"2024-07-02T16:35:20.379Z","phase":"","brief_title":"Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases","source_id_and_acronym":"NCT04167605 - BC-BOMET","lead_sponsor":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","biomarkers":" SENP1","pipe":"","alterations":" ","tags":["SENP1"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 01/13/2020","start_date":" 01/13/2020","primary_txt":" Primary completion: 09/12/2024","primary_completion_date":" 09/12/2024","study_txt":" Completion: 11/12/2024","study_completion_date":" 11/12/2024","last_update_posted":"2024-02-07"},{"id":"ac33e880-4daf-4a4c-8744-9e2b75bfb761","acronym":"","url":"https://clinicaltrials.gov/study/NCT03798587","created_at":"2022-10-19T07:56:08.675Z","updated_at":"2024-07-02T16:36:53.287Z","phase":"","brief_title":"Inhibition of SENP1 for the Suppression of OS Growth and Metastasis","source_id_and_acronym":"NCT03798587","lead_sponsor":"Istituto Ortopedico Galeazzi","biomarkers":" SENP1","pipe":"","alterations":" ","tags":["SENP1"],"overall_status":"Unknown status","enrollment":" Enrollment 15","initiation":"Initiation: 01/01/2020","start_date":" 01/01/2020","primary_txt":" Primary completion: 12/01/2020","primary_completion_date":" 12/01/2020","study_txt":" Completion: 12/01/2021","study_completion_date":" 12/01/2021","last_update_posted":"2019-11-22"}]